
Founded in 2004, the International Psoriasis Council (IPC) is a global non-profit organization dedicated to advancing psoriasis research and treatment by providing a forum for education, collaboration, and innovation among physicians, researchers, and other professionals working on the physical, economic, and social aspects of psoriatic skin and joint disease. IPC seeks to reach the following target constituencies:
• Key opinion leaders in the psoriasis community
• Physicians who currently treat psoriasis or who are interested in treating psoriasis
• Researchers focusing on psoriasis, psoriatic arthritis, immune-mediated diseases, or genetics
• Physician assistants, nurse practitioners, nurses, and other psoriasis patient caregivers
• Policy makers, public health agencies, and those who impact access to psoriasis treatments
• Corporate, non-profit, and individual stakeholders in the psoriasis community, and
• All those who seek unbiased, authoritative information on psoriasis.
IPC plans and implements programs and activities in three main areas: publications, consensus meetings, and live education programs.
• IPC publishes its own annual newsletter, The IPC Psoriasis Review, in which the organization selects and reviews, with commentary, the 10-12 most important publications in psoriasis for the year.
• IPC hosts small round table discussions among psoriasis opinion leaders on important topics in research and treatment with the goal of building consensus statements that can be published and distributed to other dermatologists via reputable peer-reviewed publications.
• IPC hosts live educational programs to share our knowledge and understanding of psoriasis with other professionals working in dermatology.